Cambridge Investment Research Advisors’s DURECT Corp DRRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,809
Closed -$56K 3088
2022
Q2
$56K Sell
11,809
-621
-5% -$2.97K ﹤0.01% 2933
2022
Q1
$83K Sell
12,430
-1,800
-13% -$12.5K ﹤0.01% 3040
2021
Q4
$140K Sell
14,230
-400
-3% -$4.42K ﹤0.01% 2974
2021
Q3
$187K Buy
14,630
+500
+4% +$6.78K ﹤0.01% 2827
2021
Q2
$230K Sell
14,130
-1,900
-12% -$33.1K ﹤0.01% 2698
2021
Q1
$317K Buy
+16,030
New +$360K ﹤0.01% 2240

Other funds holding DRRX

Cambridge Investment Research Advisors's DRRX Position: Q3 2022 in Review

Cambridge Investment Research Advisors sold out of DURECT Corp (DRRX) in Q3 2022, closing a stake of 11,809 shares — an estimated $56K sold.

Cambridge Investment Research Advisors first reported a position in DRRX in Q1 2021 and held it in 6 quarters. The position peaked at $317K in Q1 2021. 73 funds tracked by Wall St. Rank hold DRRX as of Q3 2022.

  • Cambridge Investment Research Advisors reported no remaining DURECT Corp position as of Q3 2022 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,809 DURECT Corp shares in Q3 2022, an estimated $56K.
  • Cambridge Investment Research Advisors first reported a position in DURECT Corp in Q1 2021 and held it in 6 quarters.
  • Cambridge Investment Research Advisors's DURECT Corp position peaked at $317K in Q1 2021.
  • 73 funds tracked by Wall St. Rank held DURECT Corp as of Q3 2022.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2022, filed 17 Oct 2022.